Therapeutic Advances in Cardiovascular Disease

You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.

该期刊遵循Sage Vancouver参考文献格式，正文中的每一处引用都必须与参考文献列表中的条目一一对应，且对应引用的拼写和年份必须一致。 模型中文摘要

The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…

该期刊遵循Sage Vancouver参考文献格式，正文中的每一处引用都必须与参考文献列表中的条目一一对应，且对应引用的拼写和年份必须一致。 模型中文摘要

Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…

该期刊遵循Sage Vancouver参考文献格式，正文中的每一处引用都必须与参考文献列表中的条目一一对应，且对应引用的拼写和年份必须一致。 模型中文摘要

Therapeutic Advances in Cardiovascular Disease is an open access, peer-reviewed journal. All accepted articles are made freely available online immediately upon publication, are published under a Creative Commons license, and hosted online in perpetuity. If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable to cover the cost of pu…

该期刊遵循Sage Vancouver参考文献格式，正文中的每一处引用都必须与参考文献列表中的条目一一对应，且对应引用的拼写和年份必须一致。 模型中文摘要

The following summary describes the peer review process for this journal: Identity transparency: Single-anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…

该期刊遵循Sage Vancouver参考文献格式，正文中的每一处引用都必须与参考文献列表中的条目一一对应，且对应引用的拼写和年份必须一致。 模型中文摘要

The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.

该期刊遵循Sage Vancouver参考文献格式，正文中的每一处引用都必须与参考文献列表中的条目一一对应，且对应引用的拼写和年份必须一致。 模型中文摘要

The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…

该期刊遵循Sage Vancouver参考文献格式，正文中的每一处引用都必须与参考文献列表中的条目一一对应，且对应引用的拼写和年份必须一致。 模型中文摘要

The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.